The ANSM, via its director general, responded to our mail on March 31.
Reminder: we are currently the only association of victims to sit at the ANSM for Luteran and Lotényl , while they were numerous for Androcur (but disappeared from the meetings!).
The association insisted for having a response by mail.
We were heard and had a complete answer to women's questions for meningiomas and progestins, beyond the already studied drugs, Androcur, Lotéran and Lotényl.
You have the answer in PDF format and complete here:
https://amavea.org/…/courrier-amavea-meningiomes-et…
We were answered on all the points addressed:
- Risk of meningiomas and progestins
- Mirena and risk of meningioma
- Possibility to go back to prescriptions of more than 24 months
-Site for declaration of undesirable effects
https://signally.social-sante.gouv.fr/psig_ihm_utilizers/index.html#/accueil
